Prostate Cancer Biopsy, Diagnoses Down During the Pandemic
However, there were no statistically significant changes in rates by race.
Prostate Cancer
Niraparib With Abiraterone + Prednisone Improves Outcomes in HRR BM+ Metastatic Castration Resistant Prostate Cancer
The phase 3 MAGNITUDE study assessed niraparib in combination with abiraterone acetate plus prednisone in patients with mCRPC with or without alterations in homologous recombination repair associated genes.
Anxiety, Depression Med Use Linked to Increased Odds of PSA Testing
Researchers used 2018 data from the National Health Interview Survey to investigate the association.
Racial Disparities in Prostate Cancer Persist Despite Equal-Access Care
Equal access to care may not be sufficient to eliminate racial and ethnic disparities in prostate cancer care, according to investigators.
Treatment-Related Regret Common in Prostate Cancer
A study of patients with localized prostate cancer showed that 13% reported treatment-related regret.
Healthy Plant-Based Diet Linked to Lower Risk for Elevated PSA
Finding from a recent study could be used in patient counseling to promote healthier lifestyle choices to reduce the likelihood of prostate biopsy, according to investigators.
Updated Screening Guidelines for 5 Cancer Types
An update on the available cancer screening guidelines, benefits/limitations, and risks for cervical, breast, prostate, colon, and lung cancers.
Metformin Possibly Beneficial in Advanced Prostate Cancer
In a randomized controlled study, adding metformin to androgen deprivation therapy for low-tumor-volume metastatic hormone-sensitive prostate cancer significantly delayed development of castration-resistant disease.
Genomic Landscape of Prostate Cancer Differs by Ancestry, but Frequency of Actionable Alterations Is Similar
The frequency of targetable alterations was roughly 22% in patients of African ancestry and those of European ancestry.
Prevalence of Uncontrolled, Untreated Cardiovascular Risk Factors in Patients With Prostate Cancer
An analysis of data from the VA healthcare system revealed a gap in recommended assessments of cardiovascular risk factors among men with prostate cancer.
- Loading...
Loading...
Next post in Men's Health Information Center
Loading... 
Loading...